Exploring the potential of cell-derived vesicles for transient delivery of gene editing payloads

K Leandro, D Rufino-Ramos, K Breyne… - Advanced Drug Delivery …, 2024 - Elsevier
Gene editing technologies have the potential to correct genetic disorders by modifying,
inserting, or deleting specific DNA sequences or genes, paving the way for a new class of …

Unlocking the therapeutic applicability of LNP-mRNA: Chemistry, formulation, and clinical strategies

X Huang, Y Ma, G Ma, Y Xia - Research, 2024 - spj.science.org
Messenger RNA (mRNA) has emerged as an innovative therapeutic modality, offering
promising avenues for the prevention and treatment of a variety of diseases. The …

RNA delivery systems

SN Bhatia, JE Dahlman - Proceedings of the National …, 2024 - National Acad Sciences
Between December 2020 and December 2021, COVID-19 vaccines prevented over 14
million deaths (1). Two of these vaccines were lipid nanoparticles (LNPs) formulated to carry …

A Lung-Expressing mRNA Delivery Platform with Tunable Activity in Hypoxic Environments

PB Tiwade, Y Ma, R VanKeulen-Miller… - Journal of the …, 2024 - ACS Publications
Messenger RNA (mRNA) delivery platforms often facilitate protein expression in the liver
following intravenous injection and have been optimized for use in normally oxygenated …

Microfluidic Platform Enables Shearless Aerosolization of Lipid Nanoparticles for mRNA Inhalation

J Kim, A Jozić, E Bloom, B Jones, M Marra… - ACS …, 2024 - ACS Publications
Leveraging the extensive surface area of the lungs for gene therapy, the inhalation route
offers distinct advantages for delivery. Clinical nebulizers that employ vibrating mesh …

Multicomponent Synthesis of Imidazole-Based Ionizable Lipids for Highly Efficient and Spleen-Selective Messenger RNA Delivery

W Dong, Z Li, T Hou, Y Shen, Z Guo… - Journal of the …, 2024 - ACS Publications
The spleen emerges as a pivotal target for mRNA delivery, prompting a continual quest for
specialized and efficient lipid nanoparticles (LNPs) designed to enhance spleen-selective …

[HTML][HTML] Nanoparticles for RNA Therapeutics: RNA delivery systems

SN Bhatia, JE Dahlman - Proceedings of the National Academy of …, 2024 - ncbi.nlm.nih.gov
Between December 2020 and December 2021, COVID-19 vaccines prevented over 14
million deaths (1). Two of these vaccines were lipid nanoparticles (LNPs) formulated to carry …

Lipid nanoparticle (LNP) mediated mRNA delivery in cardiovascular diseases: Advances in genome editing and CAR T cell therapy

S Soroudi, MR Jaafari, L Arabi - Journal of Controlled Release, 2024 - Elsevier
Cardiovascular diseases (CVDs) are the leading cause of global mortality among non-
communicable diseases. Current cardiac regeneration treatments have limitations and may …

Preformed Vesicle Approach to LNP Manufacturing Enhances Retinal mRNA Delivery

Y Eygeris, MI Henderson, AG Curtis, A Jozić… - Small, 2024 - Wiley Online Library
Complete encapsulation of nucleic acids by lipid‐based nanoparticles (LNPs) is often
thought to be one of the main prerequisites for successful nucleic acid delivery, as the lipid …

Biodistribution of lipid nanoparticle, eGFP mRNA and translated protein following subcutaneous administration in mouse

Å Sandelius, H Naseer, J Lindqvist, A Wilson… - Bioanalysis, 2024 - Taylor & Francis
Aim: Increased knowledge of biodistribution and pharmacokinetics of lipid nanoparticle
(LNP)-encapsulated mRNA drug components may aid efficacy and safety evaluation …